Company & Sponsor Intelligence
University Hospital, Strasbourg, France
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials16
Recruiting6
Completed5
Countries1
Therapeutic footprint
adhdalzheimersautismdepressionepilepsyother_psychiatryout_of_scopeparkinsons
Indexed studies
NCT06871345Perimenstrual Symptoms and Emotional Dysregulation in Autism
autism · NA
autism · NA
NCT05698589COMpassion for Psychiatric Disorders And Self-Stigma
autism · FranceNA
autism · FranceNA
NCT02878499Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?
autism · FranceNA
autism · FranceNA
NCT06214013Adaptation of Linehan's Biosocial Model to Emotional Dysregulation in Autism Spectrum Disorder
autism · FranceCOMPLETED
autism · FranceCOMPLETED
NCT03947216Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
parkinsons · FrancePHASE2
parkinsons · FrancePHASE2
NCT05832489EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
adhd · FrancePHASE3
adhd · FrancePHASE3
NCT02072642Light Therapy in Parkinson's Disease
parkinsons · FranceNA
parkinsons · FranceNA
NCT02288663Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement
out_of_scope · FranceNA
out_of_scope · FranceNA
NCT07299526Police Officers' Mental Health and Occupational Health Monitoring
other_psychiatry · FranceRECRUITING
other_psychiatry · FranceRECRUITING
NCT02410421e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression
depression · PHASE2
depression · PHASE2
NCT03948607Neural Mechanisms of Attention Lapses in Adult ADHD
adhd · FranceCOMPLETED
adhd · FranceCOMPLETED
NCT07166744Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies
alzheimers · NA
alzheimers · NA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →